Progyny, Inc. 8-K

What Happened
On February 26, 2026, Progyny, Inc. announced its financial results for the fiscal quarter and year ended December 31, 2025 and furnished a press release and a supplemental earnings presentation under Regulation FD. The press release is included as Exhibit 99.1 and the supplemental fourth-quarter 2025 earnings presentation is included as Exhibit 99.2 to the Current Report on Form 8-K. The filing is signed by CEO Peter Anevski.

Key Details

• Filing date: February 26, 2026; reporting results for the quarter and year ended December 31, 2025.
• Exhibits provided: Exhibit 99.1 — press release; Exhibit 99.2 — fourth quarter 2025 supplemental earnings presentation.
• Supplemental materials will be made available on Progyny’s investor relations site: investors.progyny.com.
• The 8-K is a Regulation FD disclosure (broad public release); no financial line-item detail is included in the 8-K text itself — see the attached exhibits for numbers and metrics.

Why It Matters
This 8-K signals Progyny’s formal public release of its quarterly and full-year 2025 earnings information. Investors should review the attached press release and supplemental presentation for revenue, profitability, guidance, and other operational metrics that can affect valuation and trading decisions. The Regulation FD filing ensures the company has broadly disclosed the results to all investors at the same time.